Why Castle Brands Inc (NYSEMKT:ROX) Shares Jumped 42%
Castle Brands Inc (NYSEMKT:ROX) shares were up 42.49% on Tuesday to $1.04 and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.65 to $1.45. The company has a market cap of $161.44 million at 160.97 million shares outstanding.
Castle Brands Inc is a company that develops and markets premium and super premium brands in the beverage alcohol categories. It is engaged in the sale of premium beverage alcohol. Its beverage alcohol categories include rum, whiskey, liqueurs, vodka and tequila. It has operations in two geographic areas: International and the United States. The company distributes its products in all 50 states of the United States and the District of Columbia.
Its brands include Gosling’s rum, Gosling’s Stormy Ginger Beer, Gosling’s Dark ‘n Stormy ready-to-drink cocktail, Jefferson’s bourbon, Jefferson’s Reserve, Jefferson’s Ocean Aged at Sea, Jefferson’s Wine Finish Collection, Jefferson’s The Manhattan: Barrel Finished Cocktail, Jefferson’s Chef’s Collaboration, Jefferson’s Wood Experiment, Jefferson’s Presidential Select, Jefferson’s Rye whiskey, Pallini liqueurs, Clontarf Irish whiskey, Knappogue Castle Whiskey, Brady’s Irish Cream, Boru vodka, Tierras tequila, Celtic Honey liqueur and Gozio amaretto.
In a press release, Castle Brands Inc shared that they reached an agreement to supply Goslings Stormy Ginger Beer and Goslings Stormy Diet Ginger Beer to all U.S. Walmart stores by this month.
Supplying Walmart with both the Regular and Diet Goslings Stormy Ginger Beer adds to the brand’s impressive growth and strengthens our position in the U.S. market. We are pleased that Walmart has implemented a full store roll-out. We look forward to working with Walmart to promote the continued success of Goslings Stormy Ginger Beer,” remarked John Glover, Chief Operating Officer of Castle Brands Inc.
Prior to this, several investment companies issued “buy” ratings on Castle Brands Inc shares while Director Richard Krasno recently acquired 30,000 shares of the company’s stock in a transaction on Tuesday, December 27th at $0.72 per share.
The agreement with Walmart, the world’s largest retailer, to supply approximately 4,500 stores with Goslings Stormy Ginger Beer, which we believe is the largest selling U.S. premium ginger beer, is an indication of the strength and growing value of the Goslings brand,” said Malcolm Gosling, President of Goslings-Castle Partners Inc.
Expectations of seeing the other brands that Castle Brands Inc carries on the Walmart shelves are buoying the company’s stock higher, although the recent arrangement could mean a strong influx of revenues this month and in the coming quarters.
Price gapped significantly higher upon seeing the announcement yesterday and is currently nearing record highs. Investor interest could continue to pick up in the coming days as the agreement bears fruit, possibly sustaining the strong bullish momentum for Castle Brands Inc stock.
Note, however, that the company’s latest earnings report showed breakeven figures even as revenues fell short of estimates. Whiskey revenues increased 14.5% from the year-ago quarter while Goslings Stormy Ginger Beer case sales increased 42.9% to approximately 339,000 cases. The company’s quarterly revenues of $18.31 million fell short of estimates at $20.74 million. Still, revenues reflected a 6.4% year-over-year rise on U.S. sales growth of Jefferson’s bourbons, the Irish whiskies and Goslings Stormy Ginger Beer.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.
Farallon Capital is Buying Radius Health Inc. (NASDAQ:RDUS) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Radius Health Inc. (NASDAQ:RDUS) reported that Farallon Capital has picked up 680,900 of common stock as of 2017-02-28.
The acquisition brings the aggregate amount owned by Farallon Capital to a total of 680,900 representing a 1.6% stake in the company.
For those not familiar with the company, Radius Health, Inc. is a biopharmaceutical company focused on developing therapeutics in the areas of osteoporosis, oncology and endocrine diseases. Its product candidate, the investigational drug abaloparatide for subcutaneous injection, has completed Phase III development for use in the reduction of fracture risk in postmenopausal women with osteoporosis. Its clinical pipeline also includes an investigational abaloparatide transdermal patch for use in osteoporosis and the investigational drug RAD1901 for use in hormone-driven and hormone-resistant breast cancer, and vasomotor symptoms in postmenopausal women. Its preclinical pipeline includes RAD140, a non-steroidal, selective androgen receptor modulator (SARM) under investigation for use in cancer.
A glance at Radius Health Inc. (NASDAQ:RDUS)’s key stats reveals a current market capitalization of 1.79 billion based on 43.19 Million shares outstanding and a price at last close of $43.60 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-11-25, Fitzpatrick picked up 100 at a purchase price of $60.60. This brings their total holding to 100 as of the date of the filing.
On the sell side, the most recent transaction saw Ward unload 25,000 shares at a sale price of $62.77. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Radius Health Inc. (NASDAQ:RDUS) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Franklin Ltd. Duration Income Trust (NYSEMKT:FTF) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Franklin Ltd Duration Income Trust (NYSEMKT:FTF) reported that Saba Capital has picked up 3,591,771 of common stock as of 2017-02-28.
The acquisition brings the aggregate amount owned by Saba Capital to a total of 3,591,771 representing a 13.40% stake in the company.
For those not familiar with the company, xxx Partners, L.P. is a service energy provider. The Company is a home heating oil and propane distributor and services provider. It also sells gasoline and diesel fuel to customers on a delivery only basis. The Company installs, maintains and repairs heating and air conditioning equipment, and provides these services outside its customer base, including service contracts for natural gas and other heating systems. In addition, it provides home security and plumbing services. The Company provides home heating equipment repair service and natural gas service. The Company provides services to residential and commercial customers to heat homes and buildings in the Northeast, Central and Southeast United States regions. The Company operates in Maine, New York, New Jersey, Tennessee, New Hampshire, Vermont, North Carolina, Massachusetts, Rhode Island, Pennsylvania, South Carolina, Connecticut, Maryland, Georgia, Delaware, Virginia and West Virginia, among others.
A glance at Franklin Ltd Duration Income Trust (NYSEMKT:FTF)’s key stats reveals a current market capitalization of 322.31 million based on 26.59 million shares outstanding and a price at last close of $12.13 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-09, Thompson picked up 845 at a purchase price of $11.95. This brings their total holding to 845 as of the date of the filing.
On the sell side, the most recent transaction saw Saba unload 71,044 shares at a sale price of $12.14. This brings their total holding to 3,591,771.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Franklin Ltd Duration Income Trust (NYSEMKT:FTF) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Landhuis Leroy Picked Up Enservco Corp (NYSEMKT:ENSV) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Enservco Corp (NYSEMKT:ENSV) reported that Landhuis Leroy has picked up 4,732,319 of common stock as of 2017-02-28.
The acquisition brings the aggregate amount owned by Landhuis Leroy to a total of 4,732,319 representing a 9.27% stake in the company.
For those not familiar with the company, Enservco Corporation provides well and fluid management services to the domestic onshore oil and natural gas industry. The Company’s services include frac water heating, hot oiling and acidizing (well enhancement services), and water transfer, water treatment, water hauling, fluid disposal, frac tank rental (fluid management services) and other general oilfield services. Well enhancement services consist of frac water heating, acidizing, hot oiling services and pressure testing. These services are provided by its subsidiary, Heat Waves Hot Oil Service LLC (Heat Waves), which utilize a fleet of approximately 200 custom designed trucks and other related equipment. The Company owns or leases, and operates approximately 65 water-hauling trucks and trailers equipped with pumps to move water from or into wells, tanks and other storage facilities. Each truck has a hauling capacity of approximately 130 barrels. It also provides well-site construction and roustabout services.
A glance at Enservco Corp (NYSEMKT:ENSV)’s key stats reveals a current market capitalization of 24.46 million based on 49.38 million shares outstanding and a price at last close of $0.501 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-13, Kasch picked up 50,000 at a purchase price of $0.60. This brings their total holding to 1,899,324 as of the date of the filing.
On the sell side, the most recent transaction saw Peitz unload 250,000 shares at a sale price of $0.40. This brings their total holding to 98,853.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Enservco Corp (NYSEMKT:ENSV) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Advaxis Inc (NASDAQ:ADXS) Enters Licensing Agreement with SELLAS
Advaxis Inc (NASDAQ:ADXS) shares rose 6.74% on Monday to $9.03 and an additional 1.88% to $9.20 in after-hours trading. Share prices have been trading in a 52-week range of $5.45 to $16.30. The company has a market cap of $357.65 million at 40.12 million shares outstanding.
Advaxis Inc is a clinical-stage biotechnology company that is focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins.
These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer.
In a press release, Advaxis Inc shared that it granted SELLAS a license to develop a novel cancer immunotherapy agent using Advaxis’ proprietary Lm-based antigen delivery technology with SELLAS’ patented WT1 targeted heteroclitic peptide antigen mixture. This combination has the potential to precisely direct an immune response, yielding improved clinical activity against many cancer types that express WT1. SELLAS’ future clinical studies will investigate this capability in the presence of measurable residual or recurrent disease.
WT1 is one of the most widely expressed cancer antigens and was named a top target for cancer immunotherapy by the National Cancer Institute,” said Daniel J. O’Connor, President and Chief Executive Officer of Advaxis Inc. “SELLAS’ proprietary galinpepimut-S therapy has already demonstrated clinical benefit and a strong immune response against WT1 expressing cancer cells. We believe that the use of our proprietary Lm-based antigen delivery technology with SELLAS’ proprietary technology could result in a very compelling WT1-targeted cancer immunotherapy.”
Under this agreement, Advaxis Inc will conduct all pre-clinical activities required for an IND filing then SELLAS will be responsible for all clinical development and commercial activities. Advaxis Inc will receive future payments of up to $358 million from SELLAS if certain development, regulatory, and commercial milestones are met.
The combined Advaxis-SELLAS Lm-WT1 active immunotherapy candidate has the potential to deliver SELLAS’ WT1 proprietary peptide antigens in a novel way, taking advantage of our antigen’s ability to target a wide variety of tumors of diverse immune system HLA genotypes. The delivery afforded by the Advaxis technology expands upon our current programs and should substantially enhance the clinical utility seen with galinpepimut-S, and eventually, the cancer immunotherapy armamentarium for a variety of tumors,” added Angelos Stergiou, MD, ScD h.c., Vice Chairman and Chief Executive Officer of SELLAS.
DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.
Elliott Associates, L.p. Picked Up Arconic Inc. (NYSE:ARNC) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Arconic Inc. (NYSE:ARNC) reported that Elliott Associates, L.p. has picked up 16,352,683 of common stock as of 2017-02-28.
The acquisition brings the aggregate amount owned by Elliott Associates, L.p. to a total of 16,352,683 representing a 3.7% stake in the company.
For those not familiar with the company, Arconic Inc., formerly Alcoa Inc., is engaged in providing materials and engineered products. The Company operates through segments, including Global Rolled Products, Engineered Products and Solutions, and Transportation and Construction Solutions. The Company offers engineered products and solutions, including fastening systems and rings, titanium and engineered products, power and propulsion, and forgings and extrusions. Its transportation and construction solutions include wheel and transportation products; building and construction systems, and extrusions. Its global rolled products include aerospace and automotive products; Micromill products and services, and brazing, commercial transportation and industrial solutions. It offers a range of aluminum sheet and plate products for the aerospace, automotive, commercial transportation, brazing and industrial markets. The Company’s product portfolio is focused on Arconic Micromill technology.
A glance at Arconic Inc. (NYSE:ARNC)’s key stats reveals a current market capitalization of 12.54 billion based on 438.52 Million shares outstanding and a price at last close of $28.79 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-02-24, Elliott picked up 306,000 at a purchase price of $29.27. This brings their total holding to 34,749,450 as of the date of the filing.
On the sell side, the most recent transaction saw Myers unload 4,337 shares at a sale price of $25.34. This brings their total holding to 25,688.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Arconic Inc. (NYSE:ARNC) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Texas Roadhouse Inc. (NASDAQ:TXRH) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Texas Roadhouse Inc. (NASDAQ:TXRH) reported that Taylor Wayne Kent has picked up 4,108,231 of common stock as of 2017-02-28.
The acquisition brings the aggregate amount owned by Taylor Wayne Kent to a total of 4,108,231 representing a 5.8% stake in the company.
For those not familiar with the company, Texas Roadhouse, Inc. is a restaurant company, which operates in the casual dining segment. The Company offers an assortment of seasoned and aged steaks hand-cut daily on the premises and cooked to order over open grills. In addition to steaks, the Company also offers its guests a selection of ribs, fish, seafood, chicken, pork chops, pulled pork and vegetable plates, and an assortment of hamburgers, salads and sandwiches. The Company’s entrees include over two made-from-scratch side items and it offers all its guests a free unlimited supply of roasted in-shell peanuts and fresh baked yeast rolls. The Company owns approximately 400 company restaurants and over 80 franchise restaurants in approximately 50 states and over four foreign countries. Of the over 400 restaurants the Company operates approximately 392 as Texas Roadhouse and operates over seven as Bubba’s 33 restaurants. In addition, the Company operates over two restaurants outside of the casual dining segment.
A glance at Texas Roadhouse Inc. (NASDAQ:TXRH)’s key stats reveals a current market capitalization of 2.97 billion based on 70.62 million shares outstanding and a price at last close of $42.30 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-08-03, Zarley picked up 23,800 at a purchase price of $42.23. This brings their total holding to 23,800 as of the date of the filing.
On the sell side, the most recent transaction saw Colosi unload 12,377 shares at a sale price of $48.21. This brings their total holding to 70,058.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Texas Roadhouse Inc. (NASDAQ:TXRH) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Sumichrast Martin A. is Buying Social Reality Inc. (OTCMKTS:SRAX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Social Reality Inc. (OTCMKTS:SRAX) reported that Sumichrast Martin A. has picked up 216,750 of common stock as of 2017-02-28.
The acquisition brings the aggregate amount owned by Sumichrast Martin A. to a total of 216,750 representing a 2.7% stake in the company.
For those not familiar with the company, Social Reality, Inc. is an Internet advertising and platform technology company. The Company provides tools to automate the digital advertising market. It is engaged in the sales of digital media advertising campaigns to advertising agencies and brands; sales of media inventory through real-time bidding (RTB) exchanges; sale and licensing of its SRAX Social platform and related media, and creation of custom platforms for buying media on SRAX for various brands. Its technology assists publishers in delivering their media inventory to the RTB exchanges. It provides the SRAX platform to brands and their advertising agencies. SRAX Social is a social media and loyalty platform that allows brands to launch and manage their social media initiatives. SRAX MD is an advertisement targeting and data platform for healthcare brands and medical content publishers. SRAX APP is a platform that allows publishers and content owners to launch native mobile applications through its SRAX platform.
A glance at Social Reality Inc. (OTCMKTS:SRAX)’s key stats reveals a current market capitalization of 20.06 million based on 6.66 million shares outstanding and a price at last close of $2.47 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-11-21, Hannan picked up 1,250 at a purchase price of $6.24. This brings their total holding to 3,750 as of the date of the filing.
On the sell side, the most recent transaction saw Sumichrast unload 8,929 shares at a sale price of $1.25. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Social Reality Inc. (OTCMKTS:SRAX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.